Thursday - October 15, 2026

Ataxia Telangiectasia Market Forecast 2034: Rising Demand, Novel Therapies, and Commercial Potential – DelveInsight | Acasti Pharma Inc., IntraBio Inc

The Key Ataxia Telangiectasia Companies in the market include – Quince Therapeutics S.p.A., IntraBio Inc, EMD Serono R&D, Artios Pharma Ltd, AstraZeneca, Actuate Therapeutics Inc., Acasti Pharma Inc., IntraBio Inc., and others. (Albany, New York) – October 15, 2026: DelveInsight’s … Continue reading →

Systemic Lupus Erythematosus Market to Expand Rapidly with Advancing Pipeline and Increasing Treatment Adoption by 2036 – DelveInsight | GSK, AstraZeneca, Eli Lilly and Company, Biogen, Xencor

The Key Systemic Lupus Erythematosus Companies in the market include – GlaxoSmithKline, AstraZeneca, ImmuPharma, Biogen, UCB Pharma and Biogen, Hoffmann-La Roche, Idorsia, Daiichi Sankyo, Inc., Jemincare, Alpine Immune Sciences, Inc., Bristol-Myers Squibb, AstraZeneca, Beijing Mabworks Biotech, Janssen Research & Development, … Continue reading →

Chronic Kidney Disease Market Analysis 2036: Industry Trends, Market Size, and Emerging Therapeutic Developments – DelveInsight | Tricida, Otsuka Pharmaceuticals, AstraZeneca

The Key Chronic Kidney Disease Companies in the market include – Tricida, Otsuka Pharmaceuticals, AstraZeneca, and others . (Albany, New York) – October 15, 2026: DelveInsight’s “Chronic Kidney Disease Market Insights, Epidemiology, and Market Forecast-2036″ report offers an in-depth understanding … Continue reading →

MASH Market Outlook 2036: Growth Trends, Competitive Landscape, and Future Opportunities – DelveInsight | Inventiva Pharma, Zydus Therapeutics, Novo Nordisk, Viking Therapeutics, Madrigal Pharma

The Key MASH Companies in the market include – Inventiva Pharma, Zydus Therapeutics, Novo Nordisk A/S, Viking Therapeutics, Madrigal Pharmaceuticals, Inc, Hepagene, Enyo Pharma, Galectin Therapeutics Inc., 89bio, Inc., Akero Therapeutics, Inc, AstraZeneca, Boehringer Ingelheim, Can-Regeneron Pharmaceuticals, Hepagene (Shanghai) Co., … Continue reading →

Endometrial Cancer Market Poised for Sustained Growth Amid Advancements in Treatment and Clinical Innovation – DelveInsight | AstraZeneca, Karyopharm Therapeutics, Evergreen Therapeutics, Abbott

The Key Endometrial Cancer Companies in the market include – Eli Lilly, AstraZeneca, Karyopharm Therapeutics, Evergreen Therapeutics, Abbott Laboratories, Inc., ARIAD Pharmaceuticals, Inc., Becton, Dickinson and Company, F. Hoffmann, La Roche AG, GlaxoSmithKline PLC, Merck & Co., Inc., Novartis AG. … Continue reading →